Limited utility of Mayo 2012 cardiac staging system for risk stratification of patients with advanced cardiac AL amyloidosis - analysis of a uniformly treated cohort of 1,275 patients

Haematologica. 2024 May 1;109(5):1598-1602. doi: 10.3324/haematol.2023.284348.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cohort Studies
  • Female
  • Humans
  • Immunoglobulin Light-chain Amyloidosis* / diagnosis
  • Immunoglobulin Light-chain Amyloidosis* / mortality
  • Immunoglobulin Light-chain Amyloidosis* / pathology
  • Immunoglobulin Light-chain Amyloidosis* / therapy
  • Male
  • Middle Aged
  • Prognosis
  • Risk Assessment